The current valuation score of Artelo Biosciences Inc is 8.69, ranking 68 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.03, which is -6.30% below the recent high of -0.03 and -5482.96% above the recent low of -1.51.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.